Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · IEX Real-Time Price · USD
10.03
-0.19 (-1.86%)
At close: Jul 19, 2024, 4:00 PM
10.17
+0.14 (1.40%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.36 billion as of July 22, 2024. Its market cap has decreased by -55.40% in one year.
Market Cap
1.36B
Enterprise Value
310.74M
1-Year Change
-55.40%
Ranking
Category
Stock Price
$10.03
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $1.36B, a decrease of -11.02%. That is a compound annual growth rate of -2.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.36B | 0.84% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | 3.41B | 147.35% |
| Dec 31, 2019 | 1.38B | -10.07% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioCryst Pharmaceuticals | 1.47B |
| Indivior | 1.44B |
| U.S. Physical Therapy | 1.42B |
| AdaptHealth | 1.42B |
| Longboard Pharmaceuticals | 1.40B |
| Disc Medicine | 1.35B |
| Dynavax Technologies | 1.34B |
| Nurix Therapeutics | 1.34B |